Threshold of evaluation for short stature in a pediatric endocrine clinic: differences between boys versus girls?

Joyce M Lee1, Matthew M Davis, Sarah J Clark

  • 1Division of Pediatric Endocrinology, University of Michigan, Ann Arbor, USA. joyclee@med.umich.edu

Insights

More boys than girls were evaluated for short stature in a pediatric endocrinology clinic, especially during adolescence. This study analyzed the height, age, and sex distribution of these pediatric patients.

Area of Science:

  • Pediatric Endocrinology
  • Growth Disorders

Background:

  • Short stature and poor growth are common concerns in pediatric endocrinology.
  • Understanding the demographic distribution of evaluated children is crucial for resource allocation and care planning.

Purpose of the Study:

  • To analyze the distribution of children evaluated for poor growth or short stature based on height, age, and sex.
  • To identify any demographic patterns in the utilization of pediatric endocrinology services for growth-related concerns.

Main Methods:

  • A cross-sectional study was conducted from March 2001 to July 2003.
  • Data on sex, age, height, and parental height were collected from new patient visits for short stature.

Main Results:

  • The age distribution at presentation exhibited a bimodal pattern.
  • No significant differences in height z-score or height deficit were observed between genders.
  • A higher overall number of boys compared to girls were evaluated for short stature.

Conclusions:

  • More male children than female children were evaluated, with a notable increase during adolescence.
  • The reasons for this gender disparity in seeking subspecialty care for growth issues require further investigation.
Abstract

Related Concept Videos

Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Variation: Normal Distribution, Range, and Standard Deviation02:32

Variation: Normal Distribution, Range, and Standard Deviation

In the field of psychology, there are several ways to organize measurements of a trait, feature, or characteristic (i.e., variables). Qualitative data, such as ethnicity, can be tabulated into a frequency count to provide information about the proportion, as well as the variety of groups in a sample or population. On the other hand, researchers can perform a wider set of calculations on quantitative data. The mean, mode, and median, for instance, are central tendency measures to identify a...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...